Medicinal Cannabis

LYPHE Group Opens Swiss Division With Germany And Poland To Follow By End Of Year

ONE of the UK’s fastest growing and largest cannabis companies has launched its first European operation with more to follow over the coming months. The...

Work On £12m Medicinal Cannabis Cultivation Facility Held-Up By Covid-19 UK Travel Ban

ANANDA Developments has secured £300,000 to build out the first phase of its medicinal cannabis growing research facility in Lincolnshire. In May last year the...

Children’s Dutch Epilepsy Cannabis Medicines Will Be Made In The UK To Overcome Import Impasse

A PERMANENT solution to the import impasse on children’s epilepsy cannabis medication has emerged with the Dutch manufacturer set to see the medicines made...

The UK Medical Cannabis Industry Can – And Does – Provide Epilepsy Medicines For Children In Post-Brexit Britain

Pierre Van Weperen of Grow Pharma on the post-Brexit issue surrounding the import of epilepsy cannabis medicines into the UK. MAINTAINING existing quality standards was...

NHS Launching Patient Registry To Support Evidence Base For Cannabis Medicines

THE NHS is to launch is first-ever cannabis patient registry in a move which signifies an ambition for the medicines to become more widely-available...

Huge Rise In UK Medical Cannabis Imports As Private Sector Steps-Up To Meet Patient Demand

NEW Government figures show a 900% increase in the number of cannabis medicines notified for import demonstrating the private sector’s growing role in fulfilling...

‘Repeat & Scale’: Grow Group Set For Expansion Into Germany, Europe And Beyond

UK innovator Grow Group is raising £6m to fund its expansion into Europe - with aims to be the global powerhouse of cannabis medicines...

New Access Scheme Aims To Deliver Medical Cannabis To Thousands Of UK Patients

PATIENTS currently frozen out by an under-performing National Health Service are being offered access to cannabis medicine through a new private sector scheme. Around 700...

Not One Medicinal Cannabis Trial Launched By NHS Since Law Change

A LACK of clinical evidence is a key reason the National Health Service offers for the paucity of medicinal cannabis prescriptions in the UK. So, one...

UK Medicinal Cannabis Impasse – ‘Companies Won’t Invest In Clinical Trials; Medics Only Want Clinical Trials’

A WORLD-LEADING cannabis professor says the UK is caught in a depressing Catch-22 with companies unwilling to invest in clinical trials and medics unwilling...

Grow Pharma Signs Partnership Deal With Australia’s Althea – Boosting UK Medical Cannabis Range by 20%

UK MEDICAL cannabis distributor Grow Pharma has boosted its patient product range by 20% after striking a new deal with Althea Group Holdings. Grow Pharma...

UK Medicinal Cannabis – A Painful Journey For Millions

THE typical patient at Sapphire Medical Clinics is a 65-year-old lady using cannabis medicine for chronic pain. This chimes with Germany - Europe’s largest medicinal...

More Than 20 Private Medicinal Cannabis Clinics Set To Fill Gap Left By NHS

A SHORTAGE of National Health Service prescriptions is boosting the growth of the private sector with over 20 UK clinics either open, or set...

German Medical Cannabis Patients To Top One Million

A REPORT into the German medical cannabis market estimates the number of patients totalled over 60,000 in less than two years since first approved. The...

Ethics Benchmark For Cannabis Industry

SOME of the world’s leading cannabis companies have signed up to a new charter aiming to support the growth of a green and responsible...

Maltese Medical Cannabis To Boost Exports

THE Maltese approach to cannabis is set to see its total value of exports increase by 30%. Malta decriminalised cannabis in 2013, and legalised medical cannabis in...

Suppliers Selected For Ireland’s Medical Cannabis Pilot

TWO companies have been approved as the first suppliers to Ireland’s recently launched medical cannabis programme. The Irish Government signed off on the launch of...

Latest news

Plans Unveiled For First National Health Service-Backed Medical Cannabis Clinical Trial

AFTER launching a patient registry earlier this year further signs the UK’s National Health Service is warming to cannabis...

Reakiro – Europe’s Leading CBD And Hemp Brand – Delivers The Complete B2B & B2C Package

IN a time when CBD products are becoming unavoidable in the health, wellness and fitness industries, it is more...

Is Luxembourg’s Quest To Introduce An Adult-Use Cannabis Programme Going Up In Smoke?

CONCERNS over Luxembourg’s intent to become the first European country to legalise adult-use cannabis have emerged. In an interview on...

Must read

Plans Unveiled For First National Health Service-Backed Medical Cannabis Clinical Trial

AFTER launching a patient registry earlier this year further...

Is Luxembourg’s Quest To Introduce An Adult-Use Cannabis Programme Going Up In Smoke?

CONCERNS over Luxembourg’s intent to become the first European...

You might also likeRELATED
Recommended to you

Markets: New $200m London Cannabis Fund, Nestlé, Institutional Investors, Aurora et al…

LONDON-based investors Chrystal Capital Partners have announced plans to...